GENOTOXICITY AND CARCINOGENICITY OF METRONIDAZOLE

被引:91
作者
DOBIAS, L
CERNA, M
ROSSNER, P
SRAM, R
机构
[1] INST HYG & EPIDEMIOL, CS-10042 PRAGUE, CZECH REPUBLIC
[2] INST EXPTL MED, CS-12000 PRAGUE, CZECH REPUBLIC
来源
MUTATION RESEARCH | 1994年 / 317卷 / 03期
关键词
METRONIDAZOLE; GENOTOXICITY; CARCINOGENICITY; TERATOGENICITY; EMBRYOTOXICITY;
D O I
10.1016/0165-1110(94)90001-9
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
[No abstract available]
引用
收藏
页码:177 / 194
页数:18
相关论文
共 120 条
[1]  
ALKAREEM AM, 1984, J SURG RES, V36, P547
[2]   PHARMACOKINETICS OF METRONIDAZOLE IN PREGNANT-WOMEN [J].
AMON, I ;
AMON, K ;
FRANKE, G ;
MOHR, C .
CHEMOTHERAPY, 1981, 27 (02) :73-79
[3]  
ANDERSEN M, 1982, ARCH PHARM CHEMI SCI, V10, P25
[4]  
ANDERSSON KE, 1981, SCAND J INFECT DIS, P60
[5]  
ANDRE L-J, 1968, Medecine Tropicale, V28, P483
[6]  
ASELTON P, 1985, OBSTET GYNECOL, V65, P451
[7]  
BARTLETT JG, 1981, JOHNS HOPKINS MED J, V149, P89
[8]  
BAUTZFREESE E, 1964, P NATL ACAD SCI USA, V52, P1289
[9]   CANCER AFTER EXPOSURE TO METRONIDAZOLE [J].
BEARD, CM ;
NOLLER, KL ;
OFALLON, WM ;
KURLAND, LT ;
DAHLIN, DC .
MAYO CLINIC PROCEEDINGS, 1988, 63 (02) :147-153
[10]   LACK OF EVIDENCE FOR CANCER DUE TO USE OF METRONIDAZOLE [J].
BEARD, CM ;
NOLLER, KL ;
OFALLON, WM ;
KURLAND, LT ;
DOCKERTY, MB .
NEW ENGLAND JOURNAL OF MEDICINE, 1979, 301 (10) :519-522